Autopsy report · NCT06296316

Real-Life Use of Transabdominal Restorelle® Meshes in Apical Prolapse Repair

“From June 08, 2024, the study device was no longer marketed in France. Therefore, the sponsor decided to terminate the study prematurely.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year before it stopped.
• 39 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Coloplast A/S

Sponsor type

Industry

Conditions

Genital Prolapse

Interventions

Restorelle Polypropylene Mesh

Participants

39

Sites

6

Countries

France

Trials that died the same way

• An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa
  “The sponsor decided to terminate the study early” (77% match in meaning)
• A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study
  “The study was terminated early as per Sponsor's decision” (76% match in meaning)
• Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera
  “The study was terminated by the sponsor” (75% match in meaning)
• Study of RP-6306 With FOLFIRI in Advanced Solid Tumors
  “Sponsor decided to terminate the study” (75% match in meaning)
• Effects of PS-IPC Supplementation on Muscle Mass and Functional Outcomes in Older Adults
  “Sponsor changed their study product and halted study.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.